6640--FY26| Thyroid Cancer Molecular Test| Orlando VA & San Juan| New Requirement
Closed Solicitation Posted
This opportunity was awarded. See the award notice from .
- Solicitation number
- 36C24826Q0337
- Agency
-
Veterans Integrated Service Network 8
Veterans Health Administration, Department of Veterans Affairs
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 621511 Medical Laboratories
- PSC
- 6640 Laboratory Equipment And Supplies
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Veterans Affairs Veterans Health Administration, through its Caribbean VA Healthcare System (San Juan, Puerto Rico) and Orlando VA Healthcare System (Orlando, Florida), is soliciting thyroid cancer molecular testing services via Request for Quotation (RFQ) 36C24826Q0337. The contractor must provide clinically validated thyroid mutation molecular panels capable of detecting genomic alterations using next-generation sequencing (NGS) technology in a CLIA-certified and CAP-accredited laboratory, with comprehensive reporting delivered within 10-14 business days of specimen receipt. Key requirements include detecting specific genetic markers (BRAF, RAS, RET/PTC, PAX8/PPARgh, TERT, TP53, ALK) with demonstrated high sensitivity and specificity through peer-reviewed validation studies, providing all collection and shipping materials with prepaid FedEx labels, and offering technical support. Evaluation criteria include technical acceptability (clinical efficacy, diagnostic performance, reporting format, and vendor qualifications), past performance demonstrating a minimum of three years' experience, and price. The deadline for submission of questions is March 2, 2026, at 12:00 p.m. EST, with all quotations due by March 9, 2026, at 4:00 p.m. EST, submitted electronically to the Contract Specialist, Yolanda Glover, at yolanda.glover@va.gov.
This is an unrestricted solicitation with no set-aside designation, issued as a firm-fixed-price indefinite quantity contract. The estimated contract value is $41.5 million, with a base period of 12 months followed by four optional 12-month renewal periods. Estimated testing quantities are 80 tests for the San Juan facility and 40 tests for the Orlando facility during the base year, with varying quantities across option years. The contractor will be required to execute a Business Associate Agreement (BAA) complying with HIPAA, HITECH Act, and related federal regulations for the handling of Protected Health Information, as well as comply with comprehensive VA information security and privacy requirements outlined in VA Handbook 6500.6 Appendix C. Performance will occur at CLIA-certified and CAP-accredited laboratory facilities, with payment processed monthly in arrears through the VA Financial Services Center in Austin, Texas, via the Tungsten e-invoice system or X12 EDI format upon certification of satisfactory service performance.
Notice text
The Caribbean VA Healthcare System and Orlando VA Healthcare System intends to solicit and award an acquisition for Thyroid Cancer Molecular Test, as defined in the Statement of Work (SOW). This will be a Base of 12-months and Four (4) 12-month options. This requirement is solicited as Unrestricted.
The Primary North American Industry Classification System (NAICS) for this acquisition is 621511 Medical Laboratories, with a related small business size standard of $41.5 Million, and FSC/PSC is 6640. This solicitation is a Request for Quote (RFQ), for a Firm-Fixed Price (FFP) requirement contract, which will be advertised as unrestricted on or before 26 February 2026, via sam.gov website.
The solicitation and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2025-06 10/01/2025. To be eligible for award, prospective offerors must be registered in the System for Award Management (SAM) Internet site, www.sam.gov. Amendments to the RFQ will be posted to this website only. It is the responsibility of the quoter to review the web page for notice of amendments, updates, or changes to the solicitation. No hard copies will be mailed. The contractor must ensure that we receive the proposal on time; NO late proposals will be accepted/ considered.
Any questions or concerns regarding this solicitation should be submitted no later than 03/02/2026 at 12:00 PM EST. No further questions will be accepted after that date and time. Please submit questions in writing via e-mail to the Contract Specialist, Yolanda Glover, at yolanda.glover@va.gov.
All quotations for this solicitation shall be submitted no later than 03/09/2026 at 4:00 PM EST. Please submit all responses to the Contract Specialist, Yolanda Glover, at yolanda.glover@va.gov Late submissions shall be treated in accordance with the solicitation provision at FAR 52.212-1(c).
*Note* To prepare / complete a Quote, See Offerors Checklist under 52.212-2 Evaluation Commercial Items.
Files
| File | Type | Posted |
|---|---|---|
| RFQ 36C24826Q0337_1.pdf | ||
| D.2 Handbook_6500.6_Appendix C 02.pdf | ||
| D.1 Business Associate Agreement 02.docx | DOCX document |
Notice history
| Notice | Type | Posted |
|---|---|---|
| 6640--FY26| Thyroid Cancer Molecular Test| Orlando VA & San Juan| | Award Notice | |
| This notice | Solicitation | |
| 6640--FY26| Thyroid Cancer Molecular Test| Orlando VA & San Juan| New Requirement | Pre-Solicitation |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity